Shattuck Labs, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Shattuck Labs, Inc. (STTK) reported Increase (Decrease) in Prepaid Expense and Other Assets of $561.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-11
- Shattuck Labs, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.64M.
- Shattuck Labs, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$1.08M.
- Shattuck Labs, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$180.00K.
- Shattuck Labs, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $382.00K.
- Shattuck Labs, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.82M.
- Shattuck Labs, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$6.37M.
- Shattuck Labs, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$10.46M, a 372.20% decline from fiscal 2022.
- Shattuck Labs, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $3.84M, a 58.56% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $561.00K 10-Q · filed 2026-08-11 | $381.00K derived: sum of 3 quarters · filed 2026-08-11 | $763.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$1.08M 10-Q · filed 2026-05-07 | -$1.26M derived: sum of 2 quarters · filed 2026-05-07 | -$874.00K derived: sum of 3 quarters · filed 2026-05-07 | -$2.17M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $202.00K derived: sum of 2 quarters · filed 2026-03-05 | -$1.09M derived: sum of 3 quarters · filed 2026-08-11 | -$1.82M 10-K · filed 2026-03-05 |
| 2025-09-30 | $382.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$915.00K derived: sum of 2 quarters · filed 2026-08-11 | -$1.64M 10-Q · filed 2025-11-06 | -$4.09M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$2.02M 10-Q · filed 2026-08-11 | -$4.47M derived: sum of 3 quarters · filed 2026-08-11 | -$4.87M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$723.00K 10-Q · filed 2026-05-07 | -$3.18M derived: sum of 2 quarters · filed 2026-05-07 | -$3.58M derived: sum of 3 quarters · filed 2026-05-07 | -$5.56M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$2.85M derived: sum of 2 quarters · filed 2026-03-05 | -$4.84M derived: sum of 3 quarters · filed 2026-03-05 | -$6.37M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$399.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.38M derived: sum of 2 quarters · filed 2025-11-06 | -$3.91M 10-Q · filed 2025-11-06 | -$2.48M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$3.51M 10-Q · filed 2025-08-14 | -$2.08M derived: sum of 3 quarters · filed 2025-08-14 | -$9.95M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$1.53M 10-Q · filed 2025-05-01 | -$98.00K derived: sum of 2 quarters · filed 2025-05-01 | -$7.96M derived: sum of 3 quarters · filed 2025-05-01 | -$10.53M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$6.43M derived: sum of 2 quarters · filed 2025-03-27 | -$9.00M derived: sum of 3 quarters · filed 2025-03-27 | -$10.46M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$7.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$10.43M derived: sum of 2 quarters · filed 2024-11-14 | -$11.89M 10-Q · filed 2024-11-14 | -$4.99M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$4.03M 10-Q · filed 2024-08-01 | $2.88M derived: sum of 3 quarters · filed 2024-08-01 | $4.10M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | -$1.46M 10-Q · filed 2024-05-02 | $5.44M derived: sum of 2 quarters · filed 2024-05-02 | $6.67M derived: sum of 3 quarters · filed 2024-05-02 | $6.08M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $8.13M derived: sum of 2 quarters · filed 2024-02-29 | $7.54M derived: sum of 3 quarters · filed 2024-02-29 | $3.84M 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $639.00K derived: sum of 2 quarters · filed 2023-11-09 | -$3.06M 10-Q · filed 2023-11-09 | $4.97M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$586.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$4.29M 10-Q · filed 2023-08-10 | $3.75M derived: sum of 3 quarters · filed 2023-08-10 | $4.10M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$3.70M 10-Q · filed 2023-05-09 | $4.33M derived: sum of 2 quarters · filed 2023-05-09 | $4.68M derived: sum of 3 quarters · filed 2023-05-09 | $5.86M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $8.38M derived: sum of 2 quarters · filed 2023-02-23 | $9.56M derived: sum of 3 quarters · filed 2023-02-23 | $9.27M 10-K · filed 2023-02-23 |
| 2021-09-30 | $349.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.53M derived: sum of 2 quarters · filed 2022-11-09 | $1.24M 10-Q · filed 2022-11-09 | $5.86M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $890.00K 10-Q · filed 2022-08-11 | $5.51M derived: sum of 3 quarters · filed 2022-08-11 | $5.83M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$289.00K 10-Q · filed 2022-05-12 | $4.33M derived: sum of 2 quarters · filed 2022-05-12 | $4.66M derived: sum of 3 quarters · filed 2022-05-12 | $6.73M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $4.94M derived: sum of 2 quarters · filed 2022-03-15 | $7.02M derived: sum of 3 quarters · filed 2022-03-15 | $6.83M 10-K · filed 2022-03-15 |
| 2020-09-30 | $323.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.40M derived: sum of 2 quarters · filed 2021-11-09 | $2.21M 10-Q · filed 2021-11-09 | $1.96M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.89M 10-Q · filed 2021-08-12 | $1.64M derived: sum of 3 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$183.00K 10-Q · filed 2021-05-10 | -$437.00K derived: sum of 2 quarters · filed 2021-05-10 | ||
| 2019-12-31 | -$254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$1.90M 10-K · filed 2021-03-16 | ||
| 2019-09-30 | -$1.65M 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |